Khartis Therapeutics, Inc.
About
What does Khartis Therapeutics, Inc. do?
Khartis Therapeutics is a biotechnology company focused on the discovery and development of novel oral small molecule therapies for patients with immune-mediated and chronic inflammatory diseases. The company leverages translational research and scientific innovation to create impactful treatments for significant unmet medical needs in the immunology space. Khartis aims to transition from traditional broad immunosuppression toward more targeted, precision-based oral therapies that offer improved…
What is Khartis Therapeutics, Inc.'s Effective Domain Rating?
StartupHub's Effective Domain Rating for Khartis Therapeutics, Inc. is 0 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority.
Is Khartis Therapeutics, Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Khartis Therapeutics, Inc. is 26 out of 100, a high risk rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
What is Khartis Therapeutics, Inc.'s revenue?
StartupHub estimates Khartis Therapeutics, Inc.'s annual revenue at $7.4M (range $1.7M to $22.7M, 34% confidence), based on comparable companies in the sector.
What is Khartis Therapeutics, Inc.'s valuation?
StartupHub estimates Khartis Therapeutics, Inc.'s effective valuation at $190.8M (range $125.0M to $300.0M, 25% confidence), based on comparable companies in the sector.
How much funding has Khartis Therapeutics, Inc. raised?
Khartis Therapeutics, Inc. has raised a total of $50M in funding. The most recent round on record is Series B.
Where is Khartis Therapeutics, Inc. headquartered?
Khartis Therapeutics, Inc. is headquartered in San Diego, United States.
When was Khartis Therapeutics, Inc. founded?
Khartis Therapeutics, Inc. was founded in 2021.
What industry does Khartis Therapeutics, Inc. operate in?
Khartis Therapeutics, Inc. operates in Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech, Biotech, MedTech.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
AI-powered platform for peptide design and discovery.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.